Stress During Deep Sedation With Propofol With and Without Alfentanil
NCT ID: NCT00997113
Last Updated: 2014-09-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
20 participants
INTERVENTIONAL
2009-10-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy
NCT01470170
Comparison of Different Propofol Formulations With or Without Remifentanil
NCT01592162
Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose.
NCT03861364
Exploratory Study of Propofol and Fentanyl Pharmacodynamics
NCT01550770
Minimal Effective Concentration of Lidocaine in Propofol Lidocaine Mixture for Relief of Pain on Propofol Injection
NCT05165303
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propofol
propofol only for deep procedural sedation
propofol
1 mg/kg IV followed by 0.5 mg/kg iv prn sedation
Propofol/alfentanil
Propofol with alfentanil for deep procedural sedation
propofol
1 mg/kg IV followed by 0.5 mg/kg iv prn sedation
alfentanil
alfentanil 10 ug/kg immediately prior to propofol dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
propofol
1 mg/kg IV followed by 0.5 mg/kg iv prn sedation
alfentanil
alfentanil 10 ug/kg immediately prior to propofol dose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* intoxication
* unable to provide informed consent
* allergy to propofol or alfentanil
* pregnant
* ASA physical status score \> 2
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hennepin Healthcare Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James R. Miner, MD
Role: PRINCIPAL_INVESTIGATOR
Hennepin Faculty Associates
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hennepin County Medical Center
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Miner JR, Moore JC, Plummer D, Gray RO, Patel S, Ho JD. Randomized clinical trial of the effect of supplemental opioids in procedural sedation with propofol on serum catecholamines. Acad Emerg Med. 2013 Apr;20(4):330-7. doi: 10.1111/acem.12110.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMRF093051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.